GSK Buys Human Genome Sciences in Friendly Deal
A slow-moving takeover battle that got hostile ended in a friendly manner on Monday as Human Genome Sciences (HGSI) agreed to be acquired by GlaxoSmithKline (GSK) for $3 billion in cash. The deal, worth $3.6 billion including debt, values HGSI at $14.25 per share, above Glaxo’s initial offer of $13 from three months ago. Human [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here